Functional Impairment of Endothelial Colony Forming Cells (ECFC) in Patients with Severe Atherosclerotic

Stéphanie Simoncini1, Simon Toupance2, Carlos Labat2

  • 1Aix Marseille Univ, INSERM, INRAE, C2VN, 13005 Marseille, France.

Insights

Atherosclerotic cardiovascular disease (ASCVD) impairs the repair capacity of endothelial progenitor cells (ECFCs), especially in severe cases. This dysfunction is linked to inflammation and cellular aging.

Area of Science:

  • Cardiovascular Research
  • Cell Biology
  • Immunology

Background:

  • Endothelial dysfunction is central to atherosclerosis development.
  • The relationship between endothelial repair mechanisms and atherosclerotic cardiovascular disease (ASCVD) severity remains incompletely understood.
  • Circulating endothelial progenitor cells (EPCs) are crucial for vascular repair.

Purpose of the Study:

  • To investigate the link between ASCVD severity, inflammation, and the function of circulating endothelial progenitor cells, specifically endothelial colony-forming cells (ECFCs).
  • To assess how ASCVD impacts the reparative and angiogenic properties of ECFCs.
  • To explore the association between ECFC alterations, inflammation, and cellular senescence.

Main Methods:

  • Quantified circulating progenitor cells (CD34+, CD45+CD34+KDR+) using flow cytometry in 243 subjects.
  • Assessed ECFC colony-forming capacity, proliferation, senescence, and vasculogenic properties via ex vivo culture.
  • Measured plasma IL-6 and VEGF-A levels using Cytokine Array.
  • Correlated ECFC function with ASCVD severity (number of vascular territories involved).

Main Results:

  • ASCVD patients exhibited increased circulating progenitor cells but impaired ECFC colony-forming capacity and angiogenic potential.
  • These functional deficits in ECFCs were dependent on ASCVD severity.
  • Impaired ECFC function correlated with an increased senescent phenotype and elevated plasma IL-6 levels.

Conclusions:

  • ASCVD progressively impairs the repair capacity of ECFCs in a severity-dependent manner.
  • This endothelial progenitor cell dysfunction occurs within a context of increased inflammation and cellular senescence.
  • Findings highlight the role of inflammation and senescence in reduced endothelial repair in ASCVD.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
27
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
45
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K